Myelofibrosis with myeloid metaplasia

Clinical trials for Myelofibrosis with myeloid metaplasia explained in plain language.

Never miss a new study

Get alerted when new Myelofibrosis with myeloid metaplasia trials appear

Sign up with your email to follow new studies for Myelofibrosis with myeloid metaplasia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Can a new daily pill shrink the spleen and ease myelofibrosis symptoms?

Disease control Not yet recruiting

This phase 2 trial is testing whether an oral drug called flonoltinib maleate can help adults with myelofibrosis, a rare bone marrow disorder that often causes an enlarged spleen and severe symptoms. The study compares three different daily doses (50 mg, 75 mg, and 100 mg) to see…

Matched conditions: MYELOFIBROSIS WITH MYELOID METAPLASIA

Phase 2 • Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd • Aim: Disease control

Last updated Aug 12, 2026 00:00 UTC

Myelofibrosis with myeloid metaplasia

Get alerted when new Myelofibrosis with myeloid metaplasia trials appear

Can a new daily pill shrink the spleen and ease myelofibrosis symptoms?